| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Revenue | $17.23B | -1.3% |
| Cost of Revenue | $9.92B | -4.9% |
| R&D Expense | $1.34B | +10.0% |
| SG&A Expense | $3.18B | +0.1% |
| Interest Expense | $233.0M | +194.9% |
| Pre-tax Income | $1.09B | -23.4% |
| Income Tax | $152.0M | -27.6% |
| Net Income | $735.0M | -35.9% |
| EPS (Basic) | $1.04 |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $2.64B | -17.1% |
| Short-term Investments | $98.0M | -21.0% |
| Accounts Receivable | $4.21B | +1.0% |
| Inventory | $6.90B | +1.3% |
| Current Assets | $16.26B | -3.2% |
| Total Assets | $43.00B | +0.9% |
| Current Liabilities | $10.41B | -3.1% |
| Line Item | 2023-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | $1.77B | +102.9% |
| Investing Cash Flow | -$1.99B | -214.4% |
| Financing Cash Flow | -$99.0M | +91.6% |
| -34.6% |
| EPS (Diluted) | $1.03 | -34.8% |
| Long-term Debt |
| $2.29B |
| +78.6% |
| Stockholders' Equity | $25.04B | -1.0% |